Priyamvada Maitre - Concepedia

Author

Priyamvada Maitre

Homi Bhabha National Institute ORCID

Also Known As

A. Goudeau, M. Maitre, Madan Maitre, P Maitre, P. Maitre, PRIYAMVADA MAITRE, Priyamvada Maitre, T. Cachon

109

Publications

785

Citations

H-Index

Concepts

All Affiliations

Homi Bhabha National Institute Tata Memorial Hospital Advanced Centre for Treatment, Research and Education in Cancer

About

Priyamvada Maitre is an author at Homi Bhabha National Institute specializing in oncology, radiation therapy, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	181
2	Health Sciences	2	2	38
3	Public Health	1	1	46
4	Global Health	1	1	46
5	International Health	1	1	46

Priyamvada Maitre

Publications

510

Citations

H-Index

Page 1

	Year	Citations
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial Vedang Murthy, Priyamvada Maitre, Sadhana Kannan, Journal of Clinical Oncology	2021	308
Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial Vedang Murthy, Priyamvada Maitre, Jatin Bhatia, Radiotherapy and Oncology UrologyRadiation MedicineRadiation TherapyMedicineRandomised Trial	2020	65
Modern Radiotherapy Technology: Obstacles and Opportunities to Access in Low- and Middle-Income Countries Priyamvada Maitre, Rahul Krishnatry, Supriya Chopra, JCO Global Oncology Radiotherapy TechnologyCancer RegistrationTreatment VerificationTata Memorial CentreRadiation Medicine	2022	46
Prospective Longitudinal Assessment of Quality of Life and Activities of Daily Living as Patient-Reported Outcome Measures in Recurrent/Progressive Glioma Treated with High-dose Salvage Re-irradiation Priyamvada Maitre, Tejpal Gupta, Jayant Sastri Goda, Clinical Oncology Quality Of LifeDaily LivingLife AssessmentRadiation TherapyRecurrent/progressive Glioma Treated	2020	23
Acute and Late Adverse Effects of Prostate-Only or Pelvic Stereotactic Radiation Therapy in Prostate Cancer: A Comparative Study Vedang Murthy, Ketaki Adsul, Priyamvada Maitre, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation MedicineSurgical OncologyRadiation TherapyLate Adverse Effects	2022	17
Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage Priyamvada Maitre, Sahil Sood, Priyanka Pathare, Radiotherapy and Oncology Radiation TherapyPotential SalvageMedicineBrachytherapyGa68-psma Petct	2022	15
Common Iliac Node-Positive Prostate Cancer Treated With Curative Radiation Therapy: N1 or M1a? Pradnya Chopade, Priyamvada Maitre, Sam David, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation MedicineRadiation TherapyGenitourinary CancerMedicine	2022	15
Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP Consortium Vedang Murthy, Indranil Mallick, Priyamvada Maitre, International Journal of Radiation OncologyBiologyPhysics	2025	11
Bone metastases in prostate cancer – Gallium-68–labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography – the better tracer? Archi Agrawal, Aravintho Natarajan, Sneha Mithun, Nuclear Medicine Communications	2022	10

Page 1